Use emerging data sources and advances in evidence methods to demonstrate product value and safety.
Demand for targeted precision medicines and the pressure to develop vaccines in record time are two important and intertwined trends – but they both face the same challenge: proving these products will be safe and effective for patients in the real world based on limited clinical data. This paper explores the unique challenges that pharma companies face in bringing these treatments and vaccines to market, and how using AI/ML platforms can improve outcomes, support label expansions and payer support, and help them establish a competitive advantage in a crowded marketplace.
Use emerging data sources and advances in evidence methods to demonstrate product value and safety.
From concept to market, we can meet your ever-increasing needs in regulatory, safety and compliance.
IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.
Learn how unparalleled data, domain expertise, and technologies enable AI-powered solutions that are purpose-built for healthcare.
Use machine learning-driven analytics to help identify promising patient subgroups, potentially preserving your investment and ensuring valuable therapies reach patients.
Discover unrealized connections and manage your product across the entire lifecycle, from research and development, compliance to launch and commercialization.